Skip to main content
An official website of the United States government
Email

International Cancer Proteogenome Consortium (ICPC)

Cancer knows no borders

International Cancer Proteogenome Consortium (ICPC)

Learn more about the ICPC and discover how the consortium is breaking down silos to advance proteogenomic cancer research worldwide.

The International Cancer Proteogenome Consortium (ICPC), is a voluntary scientific organization that provides a forum for collaboration among some of the world's leading cancer and proteogenomic research centers.

Launched in late 2016, the ICPC was catalyzed by the Cancer Moonshot (White House Fact Sheet - Australia; White House Fact Sheet - United Nations Good Summit) to encourage international cooperation and investment in cancer research and care, as well as new efforts in precision medicine.

The ICPC brings together more than a dozen countries to study the application of proteogenomic analysis in predicting cancer treatment success. Participants pledge to share data and results with researchers worldwide, hastening progress in patient care.

Access the ICPC Portal

Current institutions include (alphabetical order)

Australia

Team: Macquarie University, Children’s Medical Research Institute, Garvan Institute of Medical Research, and Bioplatforms Australia Ltd.

Cancer focus: all cancer types, including sarcoma, colorectal cancer, melanoma, childhood cancers

Canada/Germany

Team: McGill University, University of Victoria, University of British Columbia, and Leibniz Institute for Analytical Sciences

Cancer focus: lung cancer, breast cancer, colorectal cancer, melanoma, cancers in adolescents and young adults

China

Team: Shanghai Institute of Materia Medica, Chinese Academy of Science, and Fudan University

Cancer focus: liver cancer and other frequent cancer types in Chinese population

India

Team: Indian Institute of Technology Bombay, and Tata Memorial Centre

Cancer focus: breast cancer, head & neck cancer, cervical cancer

Japan

Team: National Cancer Center Japan

Cancer focus: sarcoma

South Korea

Team: Korea Institute of Science and Technology

Cancer focus: lung cancer (adenocarcinoma)

Team: Korea University

Cancer focus: gastric cancer, pancreatic ductal adenocarcinoma

Team: National Cancer Center, Korea

Cancer focus: early onset breast cancer, cervical cancer, cholangiocarcinoma, gastric cancer

Team: Daegu Gyeongbuk Institute of Science and Technology, and Kyung Hee University

Cancer focus: breast cancer, brain cancer

Spain

Team: Josep Carreras Leukaemia Research Institute

Cancer focus: leukemia

Sweden

Team: Lund University

Cancer focus: melanoma

Switzerland

Team: ETH Zürich

Cancer focus: prostate cancer, melanoma

Taiwan

Team: Academia Sinica

Cancer focus: lung cancer, breast cancer

Team: Chang Gung University

Cancer focus: oral squamous cell carcinoma, colorectal cancer

The Netherlands

Team: Amsterdam UMC

Cancer focus: colon, pancreatic, breast cancer

United Kingdom

Team: University of Manchester and University of Dundee

Cancer focus: esophageal cancer, prostate cancer

United States

Team: NCI Clinical Proteomic Tumor Analysis Consortium

Cancer focus: (potentially) glioblastoma multiforme, lung adenocarcinoma, lung squamous cell carcinoma, pancreatic ductal adenocarcinoma, clear cell kidney carcinoma, cutaneous melanoma, head and neck squamous cell carcinoma, sarcomas, uterine corpus endometrial carcinoma, acute myeloid leukemia

Learn More

Visit the ICPC Portal for completed projects, publications, news and media.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “International Cancer Proteogenome Consortium (ICPC) was originally published by the National Cancer Institute.”

Email